Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
about
Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studiesAutoimmune valvular carditisRisk of stroke in patients with rheumatism: a nationwide longitudinal population-based study.Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort.Intestinal Dysbiosis Is Associated with Altered Short-Chain Fatty Acids and Serum-Free Fatty Acids in Systemic Lupus ErythematosusMean Platelet Volume (MPV) as an indicator of disease activity and severity in lupus.Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.Mortality in Systemic Lupus Erythematosus: an Updated Review.The evolving concept of SLE comorbidities.Physical activity for paediatric rheumatic diseases: standing up against old paradigms.The rate of and risk factors for frequent hospitalization in systemic lupus erythematosus: results from the Korean lupus network registry.Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.Understanding remission in real-world lupus patients across five European countries.Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study.Development and validation of an impedance biosensor for point-of-care detection of vascular cell adhesion molecule-1 toward lupus diagnostics.Impact of Sex on Systemic Lupus Erythematosus-Related Causes of Premature Mortality in the United States.Mortality from systemic erythematosus lupus in Brazil: evaluation of causes according to the government health database.Cardiovascular training vs. resistance training for improving quality of life and physical function in patients with systemic lupus erythematosus: a randomized controlled trial.Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014).Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.Lipid Testing and Statin Prescription among Medicaid Recipients with Systemic Lupus Erythematosus, Diabetes Mellitus and the General Medicaid Population.The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GCharacteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.Risk of adverse events from different drugs for SLE: a systematic review and network meta-analysis.Red Cell Distribution Width Is Positively Correlated with Atherosclerotic Cardiovascular Disease 10-Year Risk Score, Age, and CRP in Spondyloarthritis with Axial or Peripheral DiseaseLow-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial
P2860
Q26771476-4B49A006-A0D3-4627-BB57-8EE910C34645Q26825666-F9FAC6DD-6723-46B1-80EA-CCB898E2544EQ33714074-B9CB7EF8-F060-4DB5-943F-307470FA15F7Q35567251-5472F8E9-872A-4654-9DC9-41993E789373Q36811755-FCABB1DE-9646-42DA-BD41-B4AC47EAA86EQ37598434-710CB0AB-1E0F-480B-B5D7-D2ED31986EB3Q37720493-4F1F2DD6-F279-4DD5-AF4F-33E346E01F33Q38764974-059DE958-78F6-4384-A100-08D3972EE44DQ38777770-55674782-9366-4220-BFC8-EBEE64BED73DQ39283399-3DC36556-09F0-4450-A263-EF789B42428EQ39323590-C1D84B79-48AC-4A5F-AFB5-C4DB7DA442C3Q39901205-0D54550F-A8B0-4918-B7FA-2C4BF880A363Q40156825-D74F515F-BB3E-43C6-AEDD-3038208FC979Q40243855-C0966302-0E48-4EF2-8A74-30F029D61487Q40513776-80E4859E-60E2-4F16-BC29-7B98500DD0F8Q40725518-06E28295-E8BE-4735-BE14-FC1998F0F09EQ41609147-9DD9B5C1-67EF-44E9-B565-1B71AEF0CB29Q46140324-E023CB70-A4FD-47EE-B5D1-DD591AA9A78FQ47743761-6B5611CE-4BE3-41F9-8EA7-05FE8D788445Q47922977-5AC14744-4E95-47A7-83E6-D2CBF0EBDBDBQ48249597-7C3165D3-C527-4C21-9C55-640D41045DB8Q48274065-B1C8E0A9-5182-4A89-AB14-B2B1283EA505Q50092295-EBEBE466-0D32-4285-9564-4A5454303F5DQ50571191-6173DC8C-C59A-4C1A-85E4-969448125C8CQ51832926-4B5E97D0-7B91-4CF2-AE99-4A52E0468B53Q52349399-A7536CE0-65B1-45D4-BBC7-A84D504332BBQ52592135-FD80F751-3C10-489B-848B-8467B42EDD65Q52593839-91227E03-D404-4F3B-A30A-55A4DDBCEBAFQ55091651-4FA3F851-49AA-419C-A908-BD05C59D9510Q55215256-E412C8F2-BAC1-4CA7-8A58-790E5161025FQ58549461-78E5E73B-222C-4206-A71C-37BC2DA531E3Q58732372-1F598565-1E2B-431C-836C-12564745F0CF
P2860
Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mortality and cardiovascular b ...... a US population-based cohort.
@en
Mortality and cardiovascular b ...... a US population-based cohort.
@nl
type
label
Mortality and cardiovascular b ...... a US population-based cohort.
@en
Mortality and cardiovascular b ...... a US population-based cohort.
@nl
prefLabel
Mortality and cardiovascular b ...... a US population-based cohort.
@en
Mortality and cardiovascular b ...... a US population-based cohort.
@nl
P2093
P2860
P356
P1476
Mortality and cardiovascular b ...... a US population-based cohort.
@en
P2093
Carolyn L Bell
Christie M Bartels
Jerry W Goldberg
Kevin A Buhr
Maja Visekruna
Robert T Greenlee
Swapna Nekkanti
P2860
P304
P356
10.3899/JRHEUM.130874
P407
P577
2014-02-15T00:00:00Z